{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T08:30:58Z","timestamp":1745397058422,"version":"3.37.3"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T00:00:00Z","timestamp":1674777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T00:00:00Z","timestamp":1674777600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"DOI":"10.1007\/s00431-023-04827-2","type":"journal-article","created":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T15:59:08Z","timestamp":1674835148000},"page":"1611-1618","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Management of infantile hemangiomas\u2014experience of a tertiary hospital"],"prefix":"10.1007","volume":"182","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1246-194X","authenticated-orcid":false,"given":"Rita","family":"Gomes","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3760-5121","authenticated-orcid":false,"given":"Lu\u00eds","family":"Salazar","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9782-3999","authenticated-orcid":false,"given":"Carolina","family":"Fraga","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0999-6524","authenticated-orcid":false,"given":"M\u00e1rio Rui","family":"Correia","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2776-7055","authenticated-orcid":false,"given":"Joana","family":"Barbosa-Sequeira","sequence":"additional","affiliation":[]},{"given":"Alexandre","family":"Fernandes","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2222-5943","authenticated-orcid":false,"given":"S\u00edlvia","family":"\u00c1lvares","sequence":"additional","affiliation":[]},{"given":"Jos\u00e9","family":"Banquart Leit\u00e3o","sequence":"additional","affiliation":[]},{"given":"Margarida","family":"Paiva Coelho","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2023,1,27]]},"reference":[{"issue":"4","key":"4827_CR1","first-page":"907","volume":"170","author":"A Munden","year":"2015","unstructured":"Munden A et al (2015) Prospective study of infantile hemangiomas: incidence, clinical characteristics, and association with placental anomalies. HHS Public Access 170(4):907\u2013913","journal-title":"HHS Public Access"},{"issue":"2","key":"4827_CR2","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/j.1525-1470.2008.00626.x","volume":"25","author":"C Kilcline","year":"2008","unstructured":"Kilcline C, Frieden IJ (2008) Infantile hemangiomas: how common are they? A systematic review of the medical literature. Pediatr Dermatol 25(2):168\u2013173","journal-title":"Pediatr Dermatol"},{"issue":"3","key":"4827_CR3","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.jpeds.2006.12.003","volume":"150","author":"AN Haggstrom","year":"2007","unstructured":"Haggstrom AN et al (2007) Prospective study of infantile hemangiomas: demographic, prenatal, and perinatal characteristics. J Pediatr 150(3):291\u2013294","journal-title":"J Pediatr"},{"key":"4827_CR4","doi-asserted-by":"crossref","unstructured":"Drolet BA, Esterly NB, Frieden IJ (1999)\u00a0\u201cHemangiomas in children,\u201d Prim Care\u00a0173\u2013181","DOI":"10.1056\/NEJM199907153410307"},{"key":"4827_CR5","first-page":"17","volume":"138","author":"MR Cordisco","year":"2009","unstructured":"Cordisco MR (2009) \u201cHemangiomas of infancy: epidemiology\u201d, Hemangiomas Vasc. Malformations An Atlas Diagnosis Treat 138:17\u201321","journal-title":"Malformations An Atlas Diagnosis Treat"},{"issue":"6","key":"4827_CR6","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1001\/archderm.134.6.718","volume":"134","author":"F Blei","year":"1998","unstructured":"Blei F, Walter J, Orlow SJ, Marchuk DA (1998) Familial segregation of hemangiomas and vascular malformations as an autosomal dominant trait. Arch Dermatol 134(6):718\u2013722","journal-title":"Arch Dermatol"},{"issue":"4","key":"4827_CR7","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/S0190-9622(97)70183-X","volume":"37","author":"IJ Frieden","year":"1997","unstructured":"Frieden IJ et al (1997) Guidelines of care for hemangiomas of infancy. J Am Acad Dermatol 37(4):631\u2013637","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"4827_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1542\/peds.2018-3475","volume":"143","author":"DP Krowchuk","year":"2019","unstructured":"Krowchuk DP et al (2019) Clinical practice guideline for the management of infantile hemangiomas. Pediatr 143(1):1\u201328","journal-title":"Pediatr"},{"issue":"4","key":"4827_CR9","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1002\/ajmg.10161","volume":"108","author":"JL Hand","year":"2002","unstructured":"Hand JL, Frieden IJ (2002) Vascular birthmarks of infancy: resolving nosologic confusion. Am J Med Genet 108(4):257\u2013264","journal-title":"Am J Med Genet"},{"issue":"10089","key":"4827_CR10","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0140-6736(16)00645-0","volume":"390","author":"C L\u00e9aut\u00e9-Labr\u00e8ze","year":"2017","unstructured":"L\u00e9aut\u00e9-Labr\u00e8ze C, Harper JI, Hoeger PH (2017) Infantile haemangioma. Lancet 390(10089):85\u201394","journal-title":"Lancet"},{"issue":"1","key":"4827_CR11","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1111\/j.1365-2133.2009.09493.x","volume":"162","author":"V Colonna","year":"2010","unstructured":"Colonna V, Resta L, Napoli A, Bonifazi E (2010) Placental hypoxia and neonatal haemangioma: clinical and histological observations. Br J Dermatol 162(1):208\u2013209","journal-title":"Br J Dermatol"},{"issue":"4","key":"4827_CR12","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s00403-016-1635-x","volume":"308","author":"S de Jong","year":"2016","unstructured":"de Jong S, Itinteang T, Withers AHJ, Davis PF, Tan ST (2016) Does hypoxia play a role in infantile hemangioma? Arch Dermatol Res 308(4):219\u2013227","journal-title":"Arch Dermatol Res"},{"issue":"3","key":"4827_CR13","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.bjps.2004.05.029","volume":"58","author":"J Leon-Villapalos","year":"2005","unstructured":"Leon-Villapalos J, Wolfe K, Kangesu L (2005) GLUT-1: An extra diagnostic tool to differentiate between haemangiomas and vascular malformations. Br J Plast Surg 58(3):348\u2013352","journal-title":"Br J Plast Surg"},{"issue":"2","key":"4827_CR14","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1542\/peds.2007-2767","volume":"122","author":"LC Chang","year":"2008","unstructured":"Chang LC et al (2008) Growth characteristics of infantile hemangiomas: implications for management. Pediatrics 122(2):360\u2013367","journal-title":"Pediatrics"},{"key":"4827_CR15","doi-asserted-by":"crossref","unstructured":"Tollefson\u00a0MM, Frieden IJ (2012)\u00a0\u201cEarly growth of infantile hemangiomas: what parents\u2019photographs tell us,\u201d\u00a0Pediatr 130(2)","DOI":"10.1542\/peds.2011-3683"},{"issue":"4","key":"4827_CR16","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1097\/PRS.0b013e318208d2ac","volume":"127","author":"CG Bauland","year":"2011","unstructured":"Bauland CG, L\u00fcning TH, Smit JM, Zeebregts CJ, Spauwen PHM (2011) Untreated hemangiomas: growth pattern and residual lesions. Plast Reconstr Surg 127(4):1643\u20131648","journal-title":"Plast Reconstr Surg"},{"issue":"3","key":"4827_CR17","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1097\/PRS.0b013e31825dc129","volume":"130","author":"RA Couto","year":"2012","unstructured":"Couto RA, MacLellan RA, Zurakowski D, Greene AK (2012) Infantile hemangioma: clinical assessment of the involuting phase and implications for management. Plast Reconstr Surg 130(3):619\u2013624","journal-title":"Plast Reconstr Surg"},{"issue":"11","key":"4827_CR18","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1001\/jamadermatol.2016.2905","volume":"152","author":"E Baselga","year":"2016","unstructured":"Baselga E et al (2016) Risk factors for degree and type of sequelae after involutionof untreated hemangiomas of infancy. JAMA Dermatol 152(11):1239\u20131243","journal-title":"JAMA Dermatol"},{"issue":"10","key":"4827_CR19","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.ad.2011.05.003","volume":"102","author":"I S\u00e1nchez-Carpintero","year":"2011","unstructured":"S\u00e1nchez-Carpintero I, Ruiz-Rodriguez R, L\u00f3pez-Guti\u00e9rrez JC (2011) Propranolol in the treatment of infantile hemangioma: clinical effectiveness, risks, and recommendations. Actas Dermosifiliogr 102(10):766\u2013779","journal-title":"Actas Dermosifiliogr"},{"key":"4827_CR20","unstructured":"Drolet\u00a0B (2015)\u00a0Initiation and use of propranolol for infantile hemangioma\u00a0: report of a consensus conference abstract"},{"issue":"4","key":"4827_CR21","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1001\/jamaoto.2013.6723","volume":"140","author":"NM Bauman","year":"2014","unstructured":"Bauman NM et al (2014) Propranolol vs prednisolone for symptomatic proliferating infantile hemangiomas: a randomized clinical trial. JAMA Otolaryngol - Head Neck Surg 140(4):323\u2013330","journal-title":"JAMA Otolaryngol - Head Neck Surg"},{"issue":"6","key":"4827_CR22","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1111\/bjd.12432","volume":"169","author":"CK Ahogo","year":"2013","unstructured":"Ahogo CK et al (2013) Factors associated with the relapse of infantile haemangiomas in children treated with oral propranolol. Br J Dermatol 169(6):1252\u20131256","journal-title":"Br J Dermatol"},{"key":"4827_CR23","doi-asserted-by":"crossref","unstructured":"Chamlin\u00a0SL\u00a0et al (2007)\u00a0\u201cMulticenter prospective study of ulcerated hemangiomas,\u201d J Pediatr\u00a0151(6)","DOI":"10.1016\/j.jpeds.2007.04.055"},{"issue":"1","key":"4827_CR24","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/pde.13695","volume":"36","author":"JM Martin","year":"2019","unstructured":"Martin JM, Sanchez S, Gonz\u00e1lez V, Cordero P, Ramon D (2019) Infantile hemangiomas with minimal or arrested growth: a retrospective case series. Pediatr Dermatol 36(1):125\u2013131","journal-title":"Pediatr Dermatol"},{"issue":"1","key":"4827_CR25","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/pde.13022","volume":"34","author":"EH Ma","year":"2017","unstructured":"Ma EH, Robertson SJ, Chow CW, Bekhor PS (2017) Infantile hemangioma with minimal or arrested growth: further observations on clinical and histopathologic findings of this unique but underrecognized entity. Pediatr Dermatol 34(1):64\u201371","journal-title":"Pediatr Dermatol"},{"issue":"2","key":"4827_CR26","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1111\/ijd.13442","volume":"56","author":"A Rotter","year":"2017","unstructured":"Rotter A et al (2017) Ultrasonography as an objective tool for assessment of infantile hemangioma treatment with propranolol. Int J Dermatol 56(2):190\u2013194","journal-title":"Int J Dermatol"},{"issue":"11","key":"4827_CR27","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1007\/s00247-016-3643-6","volume":"46","author":"D Menapace","year":"2016","unstructured":"Menapace D, Mitkov M, Towbin R, Hogeling M (2016) The changing face of complicated infantile hemangioma treatment. Pediatr Radiol 46(11):1494\u20131506","journal-title":"Pediatr Radiol"},{"key":"4827_CR28","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jpeds.2016.07.054","volume":"178","author":"MC Garzon","year":"2016","unstructured":"Garzon MC et al (2016) PHACE syndrome: consensus-derived diagnosis and care recommendations. J Pediatr 178:24\u201333.e2","journal-title":"J Pediatr"},{"issue":"5","key":"4827_CR29","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.jpeds.2010.05.027","volume":"157","author":"I Iacobas","year":"2010","unstructured":"Iacobas I et al (2010) LUMBAR: Association between cutaneous infantile hemangiomas of the lower body and regional congenital anomalies. J Pediatr 157(5):795\u2013801.e7","journal-title":"J Pediatr"},{"issue":"7","key":"4827_CR30","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1007\/s00431-015-2570-0","volume":"174","author":"PH Hoeger","year":"2015","unstructured":"Hoeger PH et al (2015) Treatment of infantile haemangiomas: recommendations of a European expert group. Eur J Pediatr 174(7):855\u2013865","journal-title":"Eur J Pediatr"},{"issue":"8","key":"4827_CR31","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1056\/NEJMoa1404710","volume":"372","author":"C L\u00e9aut\u00e9-Labr\u00e8ze","year":"2015","unstructured":"L\u00e9aut\u00e9-Labr\u00e8ze C et al (2015) A randomized, controlled trial of oral propranolol in infantile hemangioma. N Engl J Med 372(8):735\u2013746","journal-title":"N Engl J Med"},{"key":"4827_CR32","doi-asserted-by":"crossref","unstructured":"Shah\u00a0SD et al\u00a0(2016)\u00a0\u201cRebound growth of infantile hemangiomas after propranolol therapy,\u201d\u00a0Pediatr\u00a0137(4)","DOI":"10.1542\/peds.2015-1754"},{"issue":"1","key":"4827_CR33","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/bjd.12417","volume":"169","author":"S Causs\u00e9","year":"2013","unstructured":"Causs\u00e9 S et al (2013) Propranolol-resistant infantile haemangiomas. Br J Dermatol 169(1):125\u2013129","journal-title":"Br J Dermatol"},{"issue":"3","key":"4827_CR34","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1111\/bjd.14233","volume":"174","author":"E Wedgeworth","year":"2016","unstructured":"Wedgeworth E et al (2016) Propranolol in the treatment of infantile haemangiomas: lessons from the European Propranolol in the Treatment of Complicated Haemangiomas (PITCH) Taskforce survey. Br J Dermatol 174(3):594\u2013601","journal-title":"Br J Dermatol"},{"key":"4827_CR35","doi-asserted-by":"crossref","unstructured":"Chang\u00a0L et al (2017)\u00a0\u201cWhen to stop propranolol for infantile hemangioma,\u201d Sci Rep 7:1\u20137","DOI":"10.1038\/srep43292"},{"key":"4827_CR36","doi-asserted-by":"crossref","unstructured":"Thai T, Wang CY, Chang CY, Brown JD (2019)\u00a0\u201cCentral nervous system effects of oral propranolol for infantile hemangioma: a systematic review and meta-analysis,\u201d J Clin Med\u00a08(2)\u00a0","DOI":"10.3390\/jcm8020268"},{"issue":"4","key":"4827_CR37","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1001\/jama.2015.13969","volume":"315","author":"S Prey","year":"2016","unstructured":"Prey S et al (2016) Safety of propranolol therapy for severe infantile hemangioma. JAMA - J Am Med Assoc 315(4):413\u2013415","journal-title":"JAMA - J Am Med Assoc"},{"key":"4827_CR38","first-page":"2019","volume":"2016","author":"X Li","year":"2019","unstructured":"Li X, Yang K, Li H, Huo R (2019) Propranolol treatment for infantile hemangiomas: short-term adverse effects and follow-up to age two. Biomed Res Int 2016:2019","journal-title":"Biomed Res Int"},{"issue":"7","key":"4827_CR39","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1001\/archderm.136.7.905","volume":"136","author":"DW Metry","year":"2000","unstructured":"Metry DW, Hebert AA (2000) Benign cutaneous vascular tumors of infancy: when to worry, what to do. Arch Dermatol 136(7):905\u2013914","journal-title":"Arch Dermatol"},{"issue":"3","key":"4827_CR40","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.jaad.2015.10.021","volume":"74","author":"MD Boos","year":"2016","unstructured":"Boos MD, Castelo-Soccio L (2016) Experience with topical timolol maleate for the treatment of ulcerated infantile hemangiomas (IH). J Am Acad Dermatol 74(3):567\u2013570","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"4827_CR41","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/pde.13816","volume":"36","author":"DB Mannschreck","year":"2019","unstructured":"Mannschreck DB, Huang AH, Lie E, Psoter K, Puttgen K (2019) Topical timolol as adjunct therapy to shorten oral propranolol therapy for infantile hemangiomas. Pediatr Dermatol 36(3):283\u2013289","journal-title":"Pediatr Dermatol"},{"issue":"8","key":"4827_CR42","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.bjps.2005.04.029","volume":"58","author":"JN Mcheik","year":"2005","unstructured":"Mcheik JN, Renauld V, Duport G, Vergnes P, Levard G (2005) Surgical treatment of haemangioma in infants. Br J Plast Surg 58(8):1067\u20131072","journal-title":"Br J Plast Surg"},{"issue":"3","key":"4827_CR43","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/lsm.22455","volume":"48","author":"S Chinnadurai","year":"2016","unstructured":"Chinnadurai S, Sathe NA, Surawicz T (2016) Laser treatment of infantile hemangioma: a systematic review. Lasers Surg Med 48(3):221\u2013233","journal-title":"Lasers Surg Med"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-023-04827-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-023-04827-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-023-04827-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T07:32:29Z","timestamp":1683703949000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-023-04827-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,27]]},"references-count":43,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,4]]}},"alternative-id":["4827"],"URL":"https:\/\/doi.org\/10.1007\/s00431-023-04827-2","relation":{},"ISSN":["1432-1076"],"issn-type":[{"type":"electronic","value":"1432-1076"}],"subject":[],"published":{"date-parts":[[2023,1,27]]},"assertion":[{"value":"20 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research complies with all the relevant national regulations and institutional policies and is in accordance to the tenets of the Helsinki Declaration. The study was approved by the Ethics Committee of Centro Hospitalar Universit\u00e1rio do Porto and Institute of Biomedical Sciences Abel Salazar.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}